Insights & Analysis

The BioCompute Blog

Expert perspectives on life sciences AI governance, regulatory compliance, and the technology shaping the future of bio-intelligence.

Featured

regulatory

EU AI Act and Life Sciences: What August 2, 2026 Means for Your AI Pipeline

The EU AI Act enforcement deadline is approaching fast. Here's what life sciences organizations need to know about compliance, evidence requirements, and why starting now is critical.

All Articles

technology

Why GPU-Accelerated Compliance Changes Everything for Life Sciences

BioCompute joins NVIDIA Inception to bring H100 GPU acceleration to regulatory evidence generation. Here's what that means for the future of life sciences AI.

Mar 135 min read

partnerships

Building in Public: BioCompute's MaRS Momentum Journey

Accepted into MaRS Momentum, Canada's premier growth accelerator. Here's what it means for BioCompute and the life sciences AI ecosystem.

Mar 164 min read

regulatory

Why Your Life Sciences AI Platform Must Be HIPAA Compliant — And What That Actually Means

HIPAA compliance for AI platforms goes far beyond encryption. Here's what life sciences organizations need to know about running AI workloads on protected health information.

Mar 167 min read

technology

AI Audit Trails: The Foundation of Regulatory Compliance for Life Sciences AI

Without a complete audit trail, your AI system is a black box to regulators. Here's how to build audit infrastructure that satisfies FDA, EU AI Act, and GxP requirements.

Mar 169 min read

Newsletter

Sign Up for Updates

AI governance insights for life sciences leaders.